AN INDIRECT ASSAY FOR CANINE LEUKOCYTE MIGRATION INHIBITORY FACTOR (LIF): DEMONSTRATION OF ITS SPECIES SPECIFICITYANSFIELD MJ; REFAAT SHALABY M; BENFER KALTREIDER H et al.1980; J. IMMUNOL. METHODS; NLD; DA. 1980; VOL. 34; NO 1; PP. 43-48; BIBL. 10 REF.Article

CANINE SURFACE ACTIVE MATERIAL AND PULMONARY LYMPHOCYTE FUNCTION STUDIES WITH MIXED-LYMPHOCYTE CULTUREANSFIELD MJ; KALTREIDER HB; BENSON BJ et al.1980; EXP. LUNG RES.; USA; DA. 1980; VOL. 1; NO 1; PP. 3-11; BIBL. 21 REF.Article

Cytokine regulation of interleukin 6 production by human endothelial cellsREFAAT SHALABY, M; WAAGE, A; ESPEVIK, T et al.Cellular immunology (Print). 1989, Vol 121, Num 2, pp 372-382, issn 0008-8749Article

An overview of the history and biologic properties of tumor necrosis factorsREFAAT SHALABY, M; PENNICA, D; PALLADINO, M. A. JR et al.Springer seminars in immunopathology. 1986, Vol 9, Num 1, pp 33-37, issn 0344-4325Article

Engineering a humanized bispecific G'ab()₂ fragment for improved binding to T cellsRODRIGUES, M. L; REFAAT SHALABY, M; WERTHER, W et al.International journal of cancer. Supplement. 1992, Num 7, pp 45-50, issn 0898-6924Conference Paper

In vivo antiviral activity of recombinant murine gamma interferonREFAAT SHALABY, M; HAMILTON, E. B; BENNINGER, A. H et al.Journal of interferon research. 1985, Vol 5, Num 2, pp 339-345, issn 0197-8357Article

Prevention of the graft-versus-host reaction in newborn mice by antibodies to tumor necrosis factor-alphaREFAAT SHALABY, M; FENDLY, B; SHEEHAN, K. C et al.Transplantation. 1989, Vol 47, Num 6, pp 1057-1061, issn 0041-1337, 5 p.Article

Bispecific HER2 × CD3 antibodies enhance T-cell cytotoxicity in vitro and localize to HER2-overexpressing xenografts in nude miceREFAAT SHALABY, M; CARTER, P; MANEVAL, D et al.Clinical immunology and immunopathology (Print). 1995, Vol 74, Num 2, pp 185-192, issn 0090-1229Article

Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogeneREFAAT SHALABY, M; SHEPARD, H. M; PRESTA, L et al.The Journal of experimental medicine. 1992, Vol 175, Num 1, pp 217-225, issn 0022-1007Article

Activation of human polymorphonuclear neutrophil functions by interferon- and tumor necrosis factorsREFAAT SHALABY, M; AGGARWAL, B. B; RINDERKNECHT, E et al.The Journal of immunology (1950). 1985, Vol 135, Num 3, pp 2069-2073, issn 0022-1767Article

The involvement of human tumor necrosis factors-α and β- in the mixed lymphocyte reactionREFAAT SHALABY, M; ESPEVIK, T; RICE, G. C et al.The Journal of immunology (1950). 1988, Vol 141, Num 2, pp 499-503, issn 0022-1767Article

Characterization of the antitumor activities of human tumor necrosis factor-α and the comparison with other cytokines: induction of tumor-specific immunityPALLADINO, M. A. JR; REFAAT SHALABY, M; LIGGITT, D et al.The Journal of immunology (1950). 1987, Vol 138, Num 11, pp 4023-4032, issn 0022-1767Article

Natural killer-sensitive targets stimulate production of TNF-α- but not TNF-β (lymphotoxin) by highly purified human peripheral blood large granular lymphocytesPETERS, P. M; ORTALDO, J. R; PALLADINO, M. A. JR et al.The Journal of immunology (1950). 1986, Vol 137, Num 8, pp 2592-2598, issn 0022-1767Article